Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. The company also offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. In addition, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to Europe, Latin America, Africa, the Far East, the Middle East, and internationally. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Bal Pharma Dividend Announcement
• Bal Pharma announced a annually dividend of ₹1.20 per ordinary share which will be made payable on 2024-10-25. Ex dividend date: 2024-09-17
• Bal Pharma annual dividend for 2024 was ₹1.20
• Bal Pharma annual dividend for 2023 was ₹1.00
• Bal Pharma's trailing twelve-month (TTM) dividend yield is 1.0%
Bal Pharma Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-17 | ₹1.20 | annually | 2024-10-25 |
2023-09-18 | ₹1.00 | annually | 2023-10-25 |
2022-09-13 | ₹1.00 | annually | 2022-10-19 |
2021-09-16 | ₹1.00 | annually | 2021-10-24 |
2019-09-17 | ₹1.00 | annually | 2019-10-23 |
2018-09-14 | ₹1.00 | annually | 2018-10-22 |
2017-09-14 | ₹1.00 | annually | 2017-10-22 |
2016-09-15 | ₹1.00 | annually | 2016-10-22 |
2015-09-15 | ₹1.00 | annually | 2015-10-22 |
2014-09-12 | ₹1.00 | annually | |
2013-09-12 | ₹0.75 | annually | 2013-10-18 |
2009-09-17 | ₹0.75 | annually | 2009-11-01 |
Bal Pharma Dividend per year
Bal Pharma Dividend growth
Bal Pharma Dividend Yield
Bal Pharma current trailing twelve-month (TTM) dividend yield is 1.0%. Interested in purchasing Bal Pharma stock? Use our calculator to estimate your expected dividend yield:
Bal Pharma Financial Ratios
Bal Pharma Dividend FAQ
Other factors to consider when evaluating Bal Pharma as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bal Pharma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bal Pharma's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bal Pharma publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bal Pharma distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bal Pharma are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bal Pharma sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bal Pharma distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bal Pharma declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bal Pharma's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bal Pharma's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.